Therapeutic Chemotypes

Therapeutic chemotypes represent cannabis plants bred and selected for specific cannabinoid and terpene profiles rather than THC dominance alone. These lineages prioritize compounds like CBD, CBG, CBC, and balanced THC:CBD ratios, often derived from landrace or pharmaceutical breeding programs. Breeders working in this category typically employ multi-generational selection and chemotype testing to stabilize desired molecular profiles. Therapeutic chemotypes are not a single strain family but rather a breeding classification used across diverse genetic backgrounds—from Harlequin and Charlotte's Web lineages to CBD-dominant Indica and Sativa crosses. Understanding chemotype breeding requires knowledge of both cannabinoid inheritance patterns and terpene stability across growing conditions.

Breeders use therapeutic chemotype selection to develop consistent, non-THC-dominant cultivars for specific market segments and research purposes. Chemotype stabilization typically requires multi-year backcrossing programs and laboratory cannabinoid testing to ensure trait expression across generations.